nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—AKR1C3—polycystic ovary syndrome	0.768	1	CbGaD
Naproxen—UGT1A1—urine—polycystic ovary syndrome	0.00695	0.141	CbGeAlD
Naproxen—PTGS2—ovarian follicle—polycystic ovary syndrome	0.00609	0.123	CbGeAlD
Naproxen—Reaction gastrointestinal—Metformin—polycystic ovary syndrome	0.00434	0.0671	CcSEcCtD
Naproxen—Tooth abscess—Metformin—polycystic ovary syndrome	0.00347	0.0536	CcSEcCtD
Naproxen—CYP1A2—urine—polycystic ovary syndrome	0.00308	0.0623	CbGeAlD
Naproxen—CYP2C9—urine—polycystic ovary syndrome	0.00292	0.0591	CbGeAlD
Naproxen—Appetite absent—Metformin—polycystic ovary syndrome	0.00291	0.045	CcSEcCtD
Naproxen—Agomelatine—MTNR1B—polycystic ovary syndrome	0.00259	0.431	CrCbGaD
Naproxen—Respiratory distress—Metformin—polycystic ovary syndrome	0.00228	0.0353	CcSEcCtD
Naproxen—Nail disorder—Metformin—polycystic ovary syndrome	0.00223	0.0345	CcSEcCtD
Naproxen—Heartburn—Metformin—polycystic ovary syndrome	0.00211	0.0326	CcSEcCtD
Naproxen—AKR1C3—adrenal cortex—polycystic ovary syndrome	0.002	0.0404	CbGeAlD
Naproxen—AKR1C3—endometrium—polycystic ovary syndrome	0.00178	0.0361	CbGeAlD
Naproxen—Blood disorder—Metformin—polycystic ovary syndrome	0.00174	0.0268	CcSEcCtD
Naproxen—AKR1C3—uterus—polycystic ovary syndrome	0.00164	0.0333	CbGeAlD
Naproxen—AKR1C3—pituitary gland—polycystic ovary syndrome	0.00161	0.0327	CbGeAlD
Naproxen—AKR1C3—adipose tissue—polycystic ovary syndrome	0.00161	0.0325	CbGeAlD
Naproxen—AKR1C3—adrenal gland—polycystic ovary syndrome	0.00144	0.0292	CbGeAlD
Naproxen—UGT2B7—endocrine gland—polycystic ovary syndrome	0.00136	0.0274	CbGeAlD
Naproxen—AKR1C3—female gonad—polycystic ovary syndrome	0.00134	0.0272	CbGeAlD
Naproxen—AKR1C3—vagina—polycystic ovary syndrome	0.00134	0.027	CbGeAlD
Naproxen—Lightheadedness—Metformin—polycystic ovary syndrome	0.0013	0.02	CcSEcCtD
Naproxen—UGT1A1—endocrine gland—polycystic ovary syndrome	0.00115	0.0233	CbGeAlD
Naproxen—Renal impairment—Metformin—polycystic ovary syndrome	0.00111	0.0171	CcSEcCtD
Naproxen—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00108	0.0167	CcSEcCtD
Naproxen—Ibuprofen—PLAT—polycystic ovary syndrome	0.00104	0.174	CrCbGaD
Naproxen—Migraine—Metformin—polycystic ovary syndrome	0.00104	0.016	CcSEcCtD
Naproxen—Indomethacin—AKR1C3—polycystic ovary syndrome	0.00102	0.169	CrCbGaD
Naproxen—Dehydration—Metformin—polycystic ovary syndrome	0.000978	0.0151	CcSEcCtD
Naproxen—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000971	0.015	CcSEcCtD
Naproxen—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.000961	0.0149	CcSEcCtD
Naproxen—Breast disorder—Metformin—polycystic ovary syndrome	0.000951	0.0147	CcSEcCtD
Naproxen—Cramp muscle—Metformin—polycystic ovary syndrome	0.000947	0.0146	CcSEcCtD
Naproxen—Abdominal distension—Metformin—polycystic ovary syndrome	0.000915	0.0141	CcSEcCtD
Naproxen—Influenza—Metformin—polycystic ovary syndrome	0.000909	0.0141	CcSEcCtD
Naproxen—ALB—adrenal gland—polycystic ovary syndrome	0.000895	0.0181	CbGeAlD
Naproxen—Pancreatitis—Metformin—polycystic ovary syndrome	0.000891	0.0138	CcSEcCtD
Naproxen—Angina pectoris—Metformin—polycystic ovary syndrome	0.000886	0.0137	CcSEcCtD
Naproxen—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000872	0.0135	CcSEcCtD
Naproxen—PTGS2—embryo—polycystic ovary syndrome	0.000824	0.0167	CbGeAlD
Naproxen—Drowsiness—Metformin—polycystic ovary syndrome	0.000811	0.0125	CcSEcCtD
Naproxen—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000795	0.0123	CcSEcCtD
Naproxen—SLCO1A2—endocrine gland—polycystic ovary syndrome	0.00078	0.0158	CbGeAlD
Naproxen—CYP2C8—endometrium—polycystic ovary syndrome	0.000778	0.0157	CbGeAlD
Naproxen—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000767	0.0119	CcSEcCtD
Naproxen—Rhinitis—Metformin—polycystic ovary syndrome	0.00073	0.0113	CcSEcCtD
Naproxen—Hepatitis—Metformin—polycystic ovary syndrome	0.000728	0.0112	CcSEcCtD
Naproxen—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000717	0.0111	CcSEcCtD
Naproxen—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000715	0.0111	CcSEcCtD
Naproxen—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000704	0.0142	CbGeAlD
Naproxen—Eye disorder—Metformin—polycystic ovary syndrome	0.00068	0.0105	CcSEcCtD
Naproxen—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000675	0.0104	CcSEcCtD
Naproxen—PTGS2—adrenal cortex—polycystic ovary syndrome	0.000675	0.0137	CbGeAlD
Naproxen—Angiopathy—Metformin—polycystic ovary syndrome	0.00066	0.0102	CcSEcCtD
Naproxen—Immune system disorder—Metformin—polycystic ovary syndrome	0.000657	0.0102	CcSEcCtD
Naproxen—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000656	0.0101	CcSEcCtD
Naproxen—Chills—Metformin—polycystic ovary syndrome	0.000653	0.0101	CcSEcCtD
Naproxen—Malnutrition—Metformin—polycystic ovary syndrome	0.000633	0.00979	CcSEcCtD
Naproxen—Erythema—Metformin—polycystic ovary syndrome	0.000633	0.00979	CcSEcCtD
Naproxen—PTGS1—endometrium—polycystic ovary syndrome	0.000631	0.0128	CbGeAlD
Naproxen—Flatulence—Metformin—polycystic ovary syndrome	0.000624	0.00965	CcSEcCtD
Naproxen—Muscle spasms—Metformin—polycystic ovary syndrome	0.000609	0.00942	CcSEcCtD
Naproxen—PTGS2—endometrium—polycystic ovary syndrome	0.000603	0.0122	CbGeAlD
Naproxen—Ibuprofen—BCL2—polycystic ovary syndrome	0.0006	0.0999	CrCbGaD
Naproxen—Vision blurred—Metformin—polycystic ovary syndrome	0.000597	0.00923	CcSEcCtD
Naproxen—Tremor—Metformin—polycystic ovary syndrome	0.000594	0.00918	CcSEcCtD
Naproxen—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000588	0.00909	CcSEcCtD
Naproxen—CYP2C8—vagina—polycystic ovary syndrome	0.000583	0.0118	CbGeAlD
Naproxen—PTGS1—uterus—polycystic ovary syndrome	0.000581	0.0118	CbGeAlD
Naproxen—Malaise—Metformin—polycystic ovary syndrome	0.000571	0.00883	CcSEcCtD
Naproxen—PTGS1—pituitary gland—polycystic ovary syndrome	0.000571	0.0116	CbGeAlD
Naproxen—PTGS1—adipose tissue—polycystic ovary syndrome	0.000568	0.0115	CbGeAlD
Naproxen—Syncope—Metformin—polycystic ovary syndrome	0.000568	0.00878	CcSEcCtD
Naproxen—Palpitations—Metformin—polycystic ovary syndrome	0.00056	0.00865	CcSEcCtD
Naproxen—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000557	0.00861	CcSEcCtD
Naproxen—PTGS2—uterus—polycystic ovary syndrome	0.000556	0.0112	CbGeAlD
Naproxen—Hypertension—Metformin—polycystic ovary syndrome	0.000547	0.00845	CcSEcCtD
Naproxen—PTGS2—pituitary gland—polycystic ovary syndrome	0.000546	0.011	CbGeAlD
Naproxen—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000545	0.011	CbGeAlD
Naproxen—PTGS2—adipose tissue—polycystic ovary syndrome	0.000543	0.011	CbGeAlD
Naproxen—Myalgia—Metformin—polycystic ovary syndrome	0.000539	0.00834	CcSEcCtD
Naproxen—Chest pain—Metformin—polycystic ovary syndrome	0.000539	0.00834	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000536	0.00828	CcSEcCtD
Naproxen—Discomfort—Metformin—polycystic ovary syndrome	0.000533	0.00824	CcSEcCtD
Naproxen—Oedema—Metformin—polycystic ovary syndrome	0.000517	0.00799	CcSEcCtD
Naproxen—Infection—Metformin—polycystic ovary syndrome	0.000514	0.00794	CcSEcCtD
Naproxen—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00051	0.0103	CbGeAlD
Naproxen—PTGS1—adrenal gland—polycystic ovary syndrome	0.00051	0.0103	CbGeAlD
Naproxen—Shock—Metformin—polycystic ovary syndrome	0.000509	0.00786	CcSEcCtD
Naproxen—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000507	0.00784	CcSEcCtD
Naproxen—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000506	0.00783	CcSEcCtD
Naproxen—Skin disorder—Metformin—polycystic ovary syndrome	0.000502	0.00776	CcSEcCtD
Naproxen—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.0005	0.00773	CcSEcCtD
Naproxen—Anorexia—Metformin—polycystic ovary syndrome	0.000493	0.00762	CcSEcCtD
Naproxen—PTGS2—adrenal gland—polycystic ovary syndrome	0.000487	0.00987	CbGeAlD
Naproxen—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000484	0.0098	CbGeAlD
Naproxen—Hypotension—Metformin—polycystic ovary syndrome	0.000483	0.00747	CcSEcCtD
Naproxen—PTGS1—female gonad—polycystic ovary syndrome	0.000475	0.00962	CbGeAlD
Naproxen—PTGS1—vagina—polycystic ovary syndrome	0.000473	0.00957	CbGeAlD
Naproxen—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000471	0.00728	CcSEcCtD
Naproxen—Paraesthesia—Metformin—polycystic ovary syndrome	0.000464	0.00718	CcSEcCtD
Naproxen—Dyspnoea—Metformin—polycystic ovary syndrome	0.000461	0.00713	CcSEcCtD
Naproxen—Somnolence—Metformin—polycystic ovary syndrome	0.00046	0.00711	CcSEcCtD
Naproxen—Dyspepsia—Metformin—polycystic ovary syndrome	0.000455	0.00704	CcSEcCtD
Naproxen—PTGS2—female gonad—polycystic ovary syndrome	0.000454	0.0092	CbGeAlD
Naproxen—PTGS2—vagina—polycystic ovary syndrome	0.000452	0.00914	CbGeAlD
Naproxen—Decreased appetite—Metformin—polycystic ovary syndrome	0.000449	0.00695	CcSEcCtD
Naproxen—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000446	0.0069	CcSEcCtD
Naproxen—Fatigue—Metformin—polycystic ovary syndrome	0.000446	0.00689	CcSEcCtD
Naproxen—PTGS1—endocrine gland—polycystic ovary syndrome	0.000442	0.00895	CbGeAlD
Naproxen—Constipation—Metformin—polycystic ovary syndrome	0.000442	0.00683	CcSEcCtD
Naproxen—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000426	0.00659	CcSEcCtD
Naproxen—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000423	0.00654	CcSEcCtD
Naproxen—PTGS2—endocrine gland—polycystic ovary syndrome	0.000423	0.00856	CbGeAlD
Naproxen—Indomethacin—PPARG—polycystic ovary syndrome	0.000422	0.0703	CrCbGaD
Naproxen—Urticaria—Metformin—polycystic ovary syndrome	0.000411	0.00635	CcSEcCtD
Naproxen—Abdominal pain—Metformin—polycystic ovary syndrome	0.000409	0.00632	CcSEcCtD
Naproxen—Asthenia—Metformin—polycystic ovary syndrome	0.000371	0.00573	CcSEcCtD
Naproxen—Pruritus—Metformin—polycystic ovary syndrome	0.000366	0.00565	CcSEcCtD
Naproxen—Diarrhoea—Metformin—polycystic ovary syndrome	0.000354	0.00547	CcSEcCtD
Naproxen—Dizziness—Metformin—polycystic ovary syndrome	0.000342	0.00529	CcSEcCtD
Naproxen—Ibuprofen—PPARG—polycystic ovary syndrome	0.000332	0.0554	CrCbGaD
Naproxen—Vomiting—Metformin—polycystic ovary syndrome	0.000329	0.00508	CcSEcCtD
Naproxen—Rash—Metformin—polycystic ovary syndrome	0.000326	0.00504	CcSEcCtD
Naproxen—Dermatitis—Metformin—polycystic ovary syndrome	0.000326	0.00503	CcSEcCtD
Naproxen—Headache—Metformin—polycystic ovary syndrome	0.000324	0.00501	CcSEcCtD
Naproxen—Nausea—Metformin—polycystic ovary syndrome	0.000307	0.00475	CcSEcCtD
Naproxen—AKR1C3—Signaling Pathways—NRG1—polycystic ovary syndrome	2.31e-05	0.000205	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.29e-05	0.000204	CbGpPWpGaD
Naproxen—AKR1C3—Disease—AKT2—polycystic ovary syndrome	2.28e-05	0.000203	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	2.28e-05	0.000203	CbGpPWpGaD
Naproxen—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	2.27e-05	0.000202	CbGpPWpGaD
Naproxen—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	2.27e-05	0.000202	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	2.27e-05	0.000202	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	2.27e-05	0.000202	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—AKR1C3—polycystic ovary syndrome	2.27e-05	0.000201	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CYP17A1—polycystic ovary syndrome	2.23e-05	0.000198	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	2.23e-05	0.000198	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	2.21e-05	0.000197	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	2.21e-05	0.000196	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	2.21e-05	0.000196	CbGpPWpGaD
Naproxen—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	2.2e-05	0.000196	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.18e-05	0.000194	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.18e-05	0.000194	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CYP19A1—polycystic ovary syndrome	2.17e-05	0.000193	CbGpPWpGaD
Naproxen—AKR1C3—Disease—SERPINE1—polycystic ovary syndrome	2.17e-05	0.000193	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.15e-05	0.000191	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	2.14e-05	0.00019	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	2.11e-05	0.000188	CbGpPWpGaD
Naproxen—PTGS2—Disease—FGF18—polycystic ovary syndrome	2.11e-05	0.000188	CbGpPWpGaD
Naproxen—ALB—Metabolism—STAR—polycystic ovary syndrome	2.1e-05	0.000187	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.1e-05	0.000187	CbGpPWpGaD
Naproxen—PTGS2—Disease—RBP4—polycystic ovary syndrome	2.09e-05	0.000186	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.09e-05	0.000186	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	2.08e-05	0.000185	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.08e-05	0.000184	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—TH—polycystic ovary syndrome	2.07e-05	0.000184	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.07e-05	0.000184	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	2.06e-05	0.000183	CbGpPWpGaD
Naproxen—ALB—Hemostasis—GNAS—polycystic ovary syndrome	2.03e-05	0.000181	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PPARG—polycystic ovary syndrome	2.01e-05	0.000179	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—LHB—polycystic ovary syndrome	2.01e-05	0.000179	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.01e-05	0.000179	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—POMC—polycystic ovary syndrome	1.99e-05	0.000177	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	1.98e-05	0.000176	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IRS2—polycystic ovary syndrome	1.98e-05	0.000176	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—INS—polycystic ovary syndrome	1.98e-05	0.000176	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.97e-05	0.000175	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.97e-05	0.000175	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	1.97e-05	0.000175	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	1.96e-05	0.000174	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.94e-05	0.000173	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GNAS—polycystic ovary syndrome	1.94e-05	0.000172	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	1.94e-05	0.000172	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	1.94e-05	0.000172	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—LEP—polycystic ovary syndrome	1.93e-05	0.000172	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—TH—polycystic ovary syndrome	1.93e-05	0.000172	CbGpPWpGaD
Naproxen—PTGS2—Disease—GAB1—polycystic ovary syndrome	1.93e-05	0.000171	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	1.9e-05	0.000169	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	1.9e-05	0.000169	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.89e-05	0.000168	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	1.88e-05	0.000167	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—SLC2A4—polycystic ovary syndrome	1.88e-05	0.000167	CbGpPWpGaD
Naproxen—PTGS2—Disease—NAMPT—polycystic ovary syndrome	1.88e-05	0.000167	CbGpPWpGaD
Naproxen—ALB—Metabolism—HMMR—polycystic ovary syndrome	1.87e-05	0.000166	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.86e-05	0.000166	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	1.85e-05	0.000164	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—NCOR1—polycystic ovary syndrome	1.85e-05	0.000164	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.83e-05	0.000163	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	1.82e-05	0.000162	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	1.8e-05	0.00016	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	1.8e-05	0.00016	CbGpPWpGaD
Naproxen—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	1.79e-05	0.000159	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.77e-05	0.000158	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CYP19A1—polycystic ovary syndrome	1.77e-05	0.000157	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.76e-05	0.000157	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.76e-05	0.000157	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	1.75e-05	0.000156	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CYP1A1—polycystic ovary syndrome	1.75e-05	0.000156	CbGpPWpGaD
Naproxen—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	1.75e-05	0.000156	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IRS1—polycystic ovary syndrome	1.73e-05	0.000153	CbGpPWpGaD
Naproxen—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	1.72e-05	0.000153	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	1.72e-05	0.000153	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.7e-05	0.000151	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	1.7e-05	0.000151	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GNAS—polycystic ovary syndrome	1.69e-05	0.00015	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.68e-05	0.00015	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.67e-05	0.000149	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	1.67e-05	0.000148	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—POMC—polycystic ovary syndrome	1.66e-05	0.000148	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—INS—polycystic ovary syndrome	1.65e-05	0.000147	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	1.64e-05	0.000146	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	1.64e-05	0.000145	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—MTHFR—polycystic ovary syndrome	1.63e-05	0.000145	CbGpPWpGaD
Naproxen—ALB—Metabolism—LHB—polycystic ovary syndrome	1.63e-05	0.000145	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	1.62e-05	0.000144	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.61e-05	0.000143	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	1.6e-05	0.000142	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IGF1—polycystic ovary syndrome	1.6e-05	0.000142	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—AKT2—polycystic ovary syndrome	1.6e-05	0.000142	CbGpPWpGaD
Naproxen—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	1.59e-05	0.000141	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GNAS—polycystic ovary syndrome	1.58e-05	0.00014	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—TH—polycystic ovary syndrome	1.57e-05	0.00014	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	1.57e-05	0.00014	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.56e-05	0.000139	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	1.55e-05	0.000138	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	1.55e-05	0.000138	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.54e-05	0.000137	CbGpPWpGaD
Naproxen—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	1.54e-05	0.000137	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	1.54e-05	0.000137	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	1.53e-05	0.000136	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	1.53e-05	0.000136	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.52e-05	0.000136	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.52e-05	0.000135	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—NCOR1—polycystic ovary syndrome	1.5e-05	0.000133	CbGpPWpGaD
Naproxen—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	1.48e-05	0.000131	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	1.47e-05	0.000131	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	1.47e-05	0.00013	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	1.46e-05	0.00013	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.45e-05	0.000129	CbGpPWpGaD
Naproxen—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	1.45e-05	0.000129	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.44e-05	0.000128	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	1.44e-05	0.000128	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	1.44e-05	0.000128	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	1.43e-05	0.000127	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.42e-05	0.000126	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.42e-05	0.000126	CbGpPWpGaD
Naproxen—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	1.42e-05	0.000126	CbGpPWpGaD
Naproxen—PTGS2—Disease—PRL—polycystic ovary syndrome	1.38e-05	0.000123	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	1.38e-05	0.000123	CbGpPWpGaD
Naproxen—ALB—Metabolism—RRM2—polycystic ovary syndrome	1.37e-05	0.000122	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.37e-05	0.000122	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	1.33e-05	0.000118	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	1.33e-05	0.000118	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—MTHFR—polycystic ovary syndrome	1.33e-05	0.000118	CbGpPWpGaD
Naproxen—ALB—Metabolism—YAP1—polycystic ovary syndrome	1.32e-05	0.000118	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PPARG—polycystic ovary syndrome	1.32e-05	0.000118	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IGF1—polycystic ovary syndrome	1.32e-05	0.000117	CbGpPWpGaD
Naproxen—ALB—Hemostasis—AKT2—polycystic ovary syndrome	1.32e-05	0.000117	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	1.31e-05	0.000116	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—POMC—polycystic ovary syndrome	1.31e-05	0.000116	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	1.3e-05	0.000116	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—INS—polycystic ovary syndrome	1.3e-05	0.000115	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	1.28e-05	0.000114	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	1.28e-05	0.000114	CbGpPWpGaD
Naproxen—ALB—Metabolism—NAMPT—polycystic ovary syndrome	1.27e-05	0.000113	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.27e-05	0.000113	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.26e-05	0.000112	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	1.26e-05	0.000112	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	1.26e-05	0.000112	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	1.26e-05	0.000112	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.25e-05	0.000111	CbGpPWpGaD
Naproxen—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	1.25e-05	0.000111	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—TH—polycystic ovary syndrome	1.25e-05	0.000111	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	1.25e-05	0.000111	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.25e-05	0.000111	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.23e-05	0.00011	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	1.22e-05	0.000109	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	1.21e-05	0.000108	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	1.19e-05	0.000106	CbGpPWpGaD
Naproxen—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	1.19e-05	0.000105	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	1.17e-05	0.000104	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.17e-05	0.000104	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	1.17e-05	0.000104	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	1.16e-05	0.000103	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	1.16e-05	0.000103	CbGpPWpGaD
Naproxen—PTGS2—Disease—NCOR1—polycystic ovary syndrome	1.16e-05	0.000103	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PPARG—polycystic ovary syndrome	1.15e-05	0.000102	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	1.14e-05	0.000102	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	1.14e-05	0.000101	CbGpPWpGaD
Naproxen—PTGS2—Disease—NRG1—polycystic ovary syndrome	1.14e-05	0.000101	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—POMC—polycystic ovary syndrome	1.14e-05	0.000101	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—INS—polycystic ovary syndrome	1.13e-05	0.0001	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	1.12e-05	9.99e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.11e-05	9.89e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	1.08e-05	9.63e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	1.08e-05	9.61e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	1.08e-05	9.58e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PPARG—polycystic ovary syndrome	1.08e-05	9.56e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—POMC—polycystic ovary syndrome	1.06e-05	9.43e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—INS—polycystic ovary syndrome	1.05e-05	9.38e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.04e-05	9.28e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	1.04e-05	9.25e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.03e-05	9.2e-05	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IL6—polycystic ovary syndrome	1.03e-05	9.16e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	1.03e-05	9.14e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—MTHFR—polycystic ovary syndrome	1.02e-05	9.11e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.02e-05	9.07e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	1.02e-05	9.06e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—TH—polycystic ovary syndrome	1.02e-05	9.03e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—TH—polycystic ovary syndrome	1.01e-05	8.98e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	9.92e-06	8.82e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	9.89e-06	8.79e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	9.83e-06	8.74e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IRS2—polycystic ovary syndrome	9.75e-06	8.67e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	9.71e-06	8.63e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	9.71e-06	8.63e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	9.61e-06	8.54e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	9.56e-06	8.5e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	9.29e-06	8.26e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	9.26e-06	8.23e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	9.24e-06	8.22e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	9.21e-06	8.18e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	8.9e-06	7.91e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.84e-06	7.86e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	8.79e-06	7.81e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	8.77e-06	7.79e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.72e-06	7.75e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—POMC—polycystic ovary syndrome	8.65e-06	7.69e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	8.61e-06	7.65e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—INS—polycystic ovary syndrome	8.6e-06	7.64e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	8.58e-06	7.63e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IRS1—polycystic ovary syndrome	8.51e-06	7.57e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	8.3e-06	7.38e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	8.3e-06	7.37e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—TH—polycystic ovary syndrome	8.27e-06	7.35e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GNAS—polycystic ovary syndrome	8.25e-06	7.33e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	8.17e-06	7.26e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—INS—polycystic ovary syndrome	8.15e-06	7.25e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	8.05e-06	7.15e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	7.9e-06	7.03e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—AKT2—polycystic ovary syndrome	7.88e-06	7e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—NCOR1—polycystic ovary syndrome	7.86e-06	6.99e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	7.56e-06	6.72e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	7.49e-06	6.66e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	7.49e-06	6.66e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	7.45e-06	6.62e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6—polycystic ovary syndrome	7.22e-06	6.42e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—TH—polycystic ovary syndrome	7.07e-06	6.28e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	6.98e-06	6.21e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	6.96e-06	6.19e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—MTHFR—polycystic ovary syndrome	6.94e-06	6.17e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	6.88e-06	6.11e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—POMC—polycystic ovary syndrome	6.86e-06	6.1e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—INS—polycystic ovary syndrome	6.83e-06	6.07e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	6.75e-06	6e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	6.46e-06	5.75e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	6.43e-06	5.72e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	6.1e-06	5.42e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	5.77e-06	5.13e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	5.68e-06	5.05e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	5.66e-06	5.03e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPARG—polycystic ovary syndrome	5.63e-06	5.01e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	5.59e-06	4.97e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—INS—polycystic ovary syndrome	5.55e-06	4.94e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—POMC—polycystic ovary syndrome	5.55e-06	4.94e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—INS—polycystic ovary syndrome	5.52e-06	4.91e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	5.5e-06	4.89e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	5.21e-06	4.63e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	4.86e-06	4.32e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	4.61e-06	4.1e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	4.55e-06	4.04e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—INS—polycystic ovary syndrome	4.52e-06	4.02e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	3.94e-06	3.5e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	3.88e-06	3.45e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—INS—polycystic ovary syndrome	3.86e-06	3.43e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6—polycystic ovary syndrome	3.56e-06	3.17e-05	CbGpPWpGaD
